Allurion Technologies Warrants (ALUR.WS)

• Market cap: $2.04M
• 1 day: -9.61%
• 5 days: -7.38%
• 1 month: -3.83%
• 3 months: -29.84%
• 6 months: -45.27%
• Year to date: -13.75%
• 1 year: -84.22%
• 5 years: -97.11%
• 10 years: -97.11%
• Sector: Healthcare
• Industry: Medical Instruments & Supplies

About: Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

Employees: 137

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

76% more capital invested

Capital invested by funds: $341K [Q3] → $601K (+$261K) [Q4]

9.03% less ownership

Funds ownership: 15.37% [Q3] → 6.35% (-9.03%) [Q4]

14% less funds holding

Funds holding: 44 [Q3] → 38 (-6) [Q4]

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

67% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 6